inflammatory myopathy is a paraneoplastic syndrome. inflammatory myopathy may be the first manifestation of underlying malignancy. it was reported in patients with colon cancer, breast cancer, ovarian cancer, lung cancer and non-hodgkin lymphoma. there are few reports regarding inflammatory myopathy in patients with gastric cancer. we want to present inflammatory myopathy as early manifestation...

In patients with haematologic malignancies such as lymphoma and leukaemia, significant increases in survival have been seen, due to advances treatment strategies. However, long-term survivors of these cancers still remain at a higher risk developing second during their lifetime, especially the fourth decade. It is well known that immunodeficiency after radiotherapy, chemotherapy, or haematopoie...

Primary breast lymphoma (PBL) is a rare disease, and few clinicohistopathologic features of the disease have been discussed in previous studies. It represents 2.2% of extranodal lymphomas and constitutes 0.04% to 0.5% of malignant breast neoplasms, despite the clinical and radiographic similarities between breast lymphoma and carcinoma, the prognosis, as reported in the literature, varies. No c...

Primary malignant breast lymphoma is rare, accounting for 0.15% of primary breast malignancies in England' and between 0.18% and 0.5 3% in the United States.2'3 This represents 2.2% of all extra-nodal lymphomas.4 We report a 75 year old female in whom mammography failed to show any radiographic suspicious features despite the presence of a clinically obvious breast mass. We present the clinical...

Primary malignant lymphoma of the breast is a rare tumor, defined as a tumor localized in the breast with or without axillary lymph-node metastases. Such a tumor is mainly found in female patients and located more frequently in the right breast. It is difficult to make primary breast lymphoma (PBL) diagnosis before operation, and PBL diagnosis is mainly based on pathological biopsy and immunohi...

INTRODUCTION The risk of malignancies in patients with rheumatoid arthritis (RA) has raised some concern, particularly with immunosuppressive approaches to disease management. METHODS We conducted a systematic review of the literature and meta-analysis characterizing the associated risk of overall malignancy and four site-specific malignancies (lymphoma, lung, colorectal, and breast cancer) i...

It is well established that rheumatoid arthritis is associated with an increased risk of lymphoma. The use of tumor-necrosis factor-α inhibitors as a therapy in rheumatoid arthritis has been related to higher incidence of lymphoma arising at atypical and/or unusual locations; however, recent data shows their safety. We report the case of a 79 year-old woman with rheumatoid arthritis treated wit...

Sir, A 63-year-old woman was referred to our institution in December 2008, with right axillary and breast swelling. Clinically, the right breast was enlarged with an ill-defined mass in the lateral half of the right breast, which appeared to be continuous with a lobulated 20cm right axillary mass [Figure 1]. There was associated swelling of the arm and dilated veins over the skin of the breast ...

Epidemiological studies and previous meta-analyses have shown that breast implant–associated anaplastic large cell lymphoma (BI-ALCL) is a distinct type of T-cell lymphoma involving the capsule or effusion surrounding a breast implant. A United States Food and Drug Administration safety communication in 2011 prompted the American Society of Plastic Surgeons (ASPS) to initiate a patient registry...

Circulating endothelial cells (CECs) were enumerated in 20 healthy controls and 76 newly diagnosed cancer patients by means of 4-color flow cytometry. In breast cancer (n = 46) and lymphoma (n = 30) patients, both resting and activated CECs were increased by 5-fold (P <.0008 vs control). CECs significantly correlated with plasma levels of vascular cell adhesion molecule-1 and vascular endotheli...